These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8691017)

  • 1. [Physiopathology and therapy of IgA nephropathy].
    Dohi K
    Nihon Naika Gakkai Zasshi; 1996 Mar; 85(3):468-73. PubMed ID: 8691017
    [No Abstract]   [Full Text] [Related]  

  • 2. [Progress on diagnosis and therapy of kidney diseases associated with Schönlein-Henoch purpura].
    Azuma T
    Nihon Naika Gakkai Zasshi; 1992 Jan; 81(1):28-30. PubMed ID: 1556458
    [No Abstract]   [Full Text] [Related]  

  • 3. [Randomized controlled clinical trials for IgA nephropathies].
    Yoshikawa T
    Nihon Jinzo Gakkai Shi; 2007; Suppl 50th Ann():123-9. PubMed ID: 17899839
    [No Abstract]   [Full Text] [Related]  

  • 4. [Guidelines for the treatment of childhood IgA nephropathy].
    Yoshikawa N; Igarashi T; Ishikura K; Kaku Y; Nakazato H; Kamei K; Kawamura T; Nakamura H; Yamamoto Y; Nakanishi K; Sako M
    Nihon Jinzo Gakkai Shi; 2008; 50(1):31-41. PubMed ID: 18318242
    [No Abstract]   [Full Text] [Related]  

  • 5. Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment.
    McIntyre CW; Fluck RJ; Lambie SH
    Clin Nephrol; 2001 Sep; 56(3):193-8. PubMed ID: 11597033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgA nephropathy: heterogeneous clinical pictures and steroid therapy in progressive cases.
    Kobayashi Y; Hiki Y; Fujii K; Kurokawa A; Kamiyana M; Tateno S
    Semin Nephrol; 1987 Dec; 7(4):382-5. PubMed ID: 3445022
    [No Abstract]   [Full Text] [Related]  

  • 7. [IgA nephropathy--pathogenesis, pathophysiology, and therapy].
    Narita I; Goto S; Kondo D; Sakatsume M; Gejyo F
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():397-402. PubMed ID: 16523921
    [No Abstract]   [Full Text] [Related]  

  • 8. [A clinico-pathological study on a long-term outcome of IgA nephropathy].
    Oohashi T
    Igaku Kenkyu; 1988 Dec; 58(6):396-410. PubMed ID: 3252679
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary IgA nephropathy: natural history and factors of importance in the progression of renal impairment.
    Ibels LS; Gyory AZ; Caterson RJ; Pollock CA; Mahony JF; Waugh DA; Roger SD; Coulshed S
    Kidney Int Suppl; 1997 Oct; 61():S67-70. PubMed ID: 9328970
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effects of protein loading on kidney function and urinary excretion of microproteins in patients with IgA nephropathy].
    Tsugawa Y; Koni I; Konoshita T; Miyazaki R; Kawai M; Tofuku Y; Takeda R
    Nihon Jinzo Gakkai Shi; 1987 Nov; 29(11):1435-41. PubMed ID: 3450900
    [No Abstract]   [Full Text] [Related]  

  • 11. Diabetic patients with IgA nephropathy and diabetic glomerulosclerosis.
    Lai FM; Li PK; Pang SW; Suen MW; Lui SF; To KF; Lai KN
    Mod Pathol; 1993 Nov; 6(6):684-90. PubMed ID: 8302809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgA nephropathy in children.
    Mitsioni A
    Nephrol Dial Transplant; 2001; 16 Suppl 6():123-5. PubMed ID: 11568269
    [No Abstract]   [Full Text] [Related]  

  • 13. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
    Moriyama T; Honda K; Nitta K; Yumura W; Nihei H
    Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [IgA-nephropathy: the most common type of glomerulonephritis].
    Mertens PR; Floege J
    Dtsch Med Wochenschr; 2003 May; 128(22):1242-6. PubMed ID: 12772083
    [No Abstract]   [Full Text] [Related]  

  • 15. Natural history of IgA nephropathy in Japan.
    Tojo S; Hatano M; Honda N; Miyahara T; Sugino N; Narita M; Sakai H
    Semin Nephrol; 1987 Dec; 7(4):386-8. PubMed ID: 3445023
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical guidelines for immunoglobulin A (IgA) nephropathy in Japan, second version.
    Tomino Y; Sakai H;
    Clin Exp Nephrol; 2003 Jun; 7(2):93-7. PubMed ID: 14586726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Markers of progression in IgA nephropathy.
    Schena FP; Gesualdo L
    J Nephrol; 2001; 14(6):554-74. PubMed ID: 11783611
    [No Abstract]   [Full Text] [Related]  

  • 18. Vasculitic IgA nephropathy: prognosis and outcome.
    Pankhurst T; Lepenies J; Nightingale P; Howie AJ; Adu D; Harper L
    Nephron Clin Pract; 2009; 112(1):c16-24. PubMed ID: 19342865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remission of proteinuria improves prognosis in IgA nephropathy.
    Reich HN; Troyanov S; Scholey JW; Cattran DC;
    J Am Soc Nephrol; 2007 Dec; 18(12):3177-83. PubMed ID: 17978307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An adolescent with IgA nephropathy and Crohn disease: pathogenetic implications.
    Takemura T; Okada M; Yagi K; Kuwajima H; Yanagida H
    Pediatr Nephrol; 2002 Oct; 17(10):863-6. PubMed ID: 12376818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.